Explore the words cloud of the uMonitorRare project. It provides you a very rough idea of what is the project "uMonitorRare" about.
The following table provides information about the project.
MEDTEP ONLINE SL
|Coordinator Country||Spain [ES]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
|Duration (year-month-day)||from 2015-02-01 to 2015-04-30|
Take a look of project's partnership.
We own and run a cloud patient monitoring platform that consists of one part for healthcare professionals: uClinics and another one for patients: uPatient. uClinics allows doctors to prescribe and assess the patient and uPatient empowers patients to understand their health treatment. We want to adapt the design of these two applications through Phase I and II funding to rare diseases and call the project uMonitorRare. uClinics and uPatient are fully functional and being used by our three largest customers in over 70 countries and 5 continents.
For Phase II, the overall objective is the technical re-design and upgrade of our uClinics and uPatient suites for rare disease patients (integration of new monitoring protocols for rare diseases, integration of new devices adapted to new diseases, integration of the Platform to Health Information Systems, multi-source data aggregation, benchmarking technology). In Phase I, we need to conduct a Technical Feasibility Study and complete a Business Plan. The uMonitorRare breakthrough ICT product will create a new market by offering an integrated rare diseases monitoring and management tool for rare disease patients. This is going to have a transformatory impact on rare disease patients who will become the universal patient at the center of attention.
According to the World Health Organization (WHO), there are nearly 7,000 rare diseases affecting 7% of world population. This means that 3 million people are affected by rare diseases throughout Spain and 30 million people are affected by rare diseases throughout Europe. Not only does this represent a major market potential, but also can it have a major impact on the way patients are treated.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UMONITORRARE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "UMONITORRARE" are provided by the European Opendata Portal: CORDIS opendata.
In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise SoftwareRead More
Osmotic Wearable Bolus Injector (oWBI) for viscous drug deliveryRead More
ScanVid - One-Click Integrated Access to Product-related Digital ContentRead More